Endo Rises As Much as 25% With Favorable Antitrust Verdict

Endo International says a federal jury in Chicago returned a verdict in favor of its subsidiaries in an antitrust trial.

• Shares rose about 25% as of 2:06pm E.T
• Trial called In re Opana® ER Antitrust Litigation
• Subsidiaries were Endo Pharmaceuticals Inc. and Endo Health Solutions Inc.
• “A trial of all plaintiffs’ claims began in June and concluded today with a verdict in favor of Endo on all counts,” company says

To view the source of this information click here

To contact the reporter on this story:
Lara Sanli in New York at lsanli@bloomberg.net

To contact the editor responsible for this ...